199 related articles for article (PubMed ID: 26634026)
1. Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes.
Connell JP; Kodali S; Cooke JP
Methodist Debakey Cardiovasc J; 2015; 11(3):176-80. PubMed ID: 26634026
[TBL] [Abstract][Full Text] [Related]
2. Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.
Meng S; Chanda P; Thandavarayan RA; Cooke JP
Antioxid Redox Signal; 2018 Jul; 29(2):205-218. PubMed ID: 29634341
[TBL] [Abstract][Full Text] [Related]
3. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy for ischemic heart disease: where are we?
LaPar DJ; Kron IL; Yang Z
Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
[TBL] [Abstract][Full Text] [Related]
5. Transflammation: Innate immune signaling in nuclear reprogramming.
Meng S; Chanda P; Thandavarayan RA; Cooke JP
Adv Drug Deliv Rev; 2017 Oct; 120():133-141. PubMed ID: 28916494
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
7. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
8. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
Lui KO; Bu L; Li RA; Chan CW
Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
[TBL] [Abstract][Full Text] [Related]
10. New era of regenerative medicine for cardiovascular diseases.
Tse HF
Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
[No Abstract] [Full Text] [Related]
11. Recent advancements in tissue engineering for stem cell-based cardiac therapies.
Le Huu A; Paul A; Xu L; Prakash S; Shum-Tim D
Ther Deliv; 2013 Apr; 4(4):503-16. PubMed ID: 23557290
[TBL] [Abstract][Full Text] [Related]
12. New and viable cells to replace lost and malfunctioning myocardial tissue.
Hassink RJ; Passier R; Goumans MJ; Mummery CL; Doevendans PA
Minerva Cardioangiol; 2004 Oct; 52(5):433-45. PubMed ID: 15514577
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
He WJ; Hou Q; Han QW; Han WD; Fu XB
Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
[TBL] [Abstract][Full Text] [Related]
15. Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease.
Wang WE; Chen X; Houser SR; Zeng C
Clin Sci (Lond); 2013 Oct; 125(7):319-27. PubMed ID: 23746375
[TBL] [Abstract][Full Text] [Related]
16. Cardiogenic differentiation and transdifferentiation of progenitor cells.
Reinecke H; Minami E; Zhu WZ; Laflamme MA
Circ Res; 2008 Nov; 103(10):1058-71. PubMed ID: 18988903
[TBL] [Abstract][Full Text] [Related]
17. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells: developmental biology to regenerative medicine.
Nelson TJ; Martinez-Fernandez A; Terzic A
Nat Rev Cardiol; 2010 Dec; 7(12):700-10. PubMed ID: 20956984
[TBL] [Abstract][Full Text] [Related]
19. Aesthetic cardiology: adipose-derived stem cells for myocardial repair.
Palpant NJ; Metzger JM
Curr Stem Cell Res Ther; 2010 Jun; 5(2):145-52. PubMed ID: 19941452
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunophenotypes in human embryonic, fetal and adult heart.
Grigore A; Arsene D; Filipoiu F; Cionca F; Enache S; Ceauşu M; Comănescu M; Stăniceanu F; Ardeleanu C
Rom J Morphol Embryol; 2012; 53(2):299-311. PubMed ID: 22732799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
